Fennec Pharmaceuticals Inc.
FENC
$7.84
-$0.34-4.16%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 22.68M | 26.63M | 40.32M | 43.05M | 51.18M |
| Total Receivables | 15.45M | 12.88M | 12.91M | 12.31M | 10.27M |
| Inventory | 1.40M | 1.06M | 1.13M | 2.14M | 2.06M |
| Prepaid Expenses | 2.44M | 3.08M | 3.07M | 4.38M | 4.49M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.00M | 466.00K | 546.00K | 283.00K | 161.00K |
| Total Current Assets | 42.98M | 44.12M | 57.97M | 62.17M | 68.17M |
|
|
|||||
| Total Current Assets | 42.98M | 44.12M | 57.97M | 62.17M | 68.17M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.43M | 822.00K | 956.00K | 989.00K | 1.02M |
| Total Assets | 46.40M | 44.95M | 58.92M | 63.16M | 69.19M |
|
|
|||||
| Total Accounts Payable | 5.28M | 3.24M | 3.87M | 4.45M | 5.20M |
| Total Accrued Expenses | 2.84M | 3.43M | 3.31M | 3.04M | 4.36M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | 2.00K | 7.00K | 12.00K | 17.00K |
| Total Finance Division Other Current Liabilities | 248.00K | 248.00K | 248.00K | 252.00K | 252.00K |
| Total Other Current Liabilities | 248.00K | 248.00K | 248.00K | 252.00K | 252.00K |
| Total Current Liabilities | 8.37M | 6.92M | 7.44M | 7.75M | 9.84M |
|
|
|||||
| Total Current Liabilities | 8.37M | 6.92M | 7.44M | 7.75M | 9.84M |
| Long-Term Debt | 19.35M | 19.34M | 32.10M | 31.78M | 31.35M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 24.56M | 24.56M | 24.56M | 24.99M | 24.99M |
| Total Liabilities | 52.28M | 50.82M | 64.09M | 64.52M | 66.18M |
|
|
|||||
| Common Stock & APIC | 213.72M | 212.57M | 211.28M | 209.36M | 208.18M |
| Retained Earnings | -220.85M | -219.68M | -217.70M | -211.96M | -206.41M |
| Treasury Stock & Other | 1.24M | 1.24M | 1.24M | 1.24M | 1.24M |
| Total Common Equity | -5.88M | -5.87M | -5.17M | -1.36M | 3.01M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -5.88M | -5.87M | -5.17M | -1.36M | 3.01M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -5.88M | -5.87M | -5.17M | -1.36M | 3.01M |
|
|
|||||